Asthma Week

HomePatientsLung Disease Week at the ATS2016 ▶ Asthma Week
Asthma Week

Asthma Week

Welcome Message

Asthma remains a significant medical problems afflicting 1 in 15 Americans and costing billions of dollars in direct costs for medications, emergency services and hospitalizations as well as indirect costs associated with lost days of work and school. Although the causes of asthma remain unknown, the recognition of the heterogeneity of the causes and of individuals' response to treatment provides important insights into tailoring therapy to a patient's needs.  Despite remarkable progress in new treatments for asthma, nearly 50% of patients' disease remains uncontrolled. Advancements in our care of patients with asthma will focus on interdisciplinary approaches using asthma educators, providers and patients to interact and to embrace important issues surrounding medication adherence and avoidance of asthma triggers. Although a cure for asthma does not exist, the future is bright for patients with asthma, enabling them to live life to the fullest.


Reynold A. Panettieri, Jr., MD

Reynold A. Panettieri, Jr., MD
Vice Chancellor for Translational Medicine and Science
Director, Rutgers Institute for Translational Medicine and Science
Professor, Robert Wood Johnson Medical School
Rutgers, The State University of New Jersey
Emeritus Professor, University of Pennsylvania
Board of Director, American Thoracic Society

Cary Sennett, MD, PhD

Cary Sennett, MD, PhD
AAFA President & CEO
Member, ATS Public Advisory Roundtable



The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma and allergies, and the oldest asthma and allergy patient group in the world. AAFA is dedicated to improving the quality of life for people with asthma and allergic diseases through education, advocacy and research